283 related articles for article (PubMed ID: 33151731)
1. The Anticipated Effects of Cannabis Scale (AECS): Initial development and validation of an affect- and valence-based expectancy measure.
Waddell JT; Corbin WR; Meier MH; Morean ME; Metrik J
Psychol Assess; 2021 Feb; 33(2):180-194. PubMed ID: 33151731
[TBL] [Abstract][Full Text] [Related]
2. The anticipated effects of simultaneous alcohol and cannabis use: Initial development and preliminary validation.
Waddell JT; King SE; Okey SA; Meier MH; Metrik J; Corbin WR
Psychol Assess; 2022 Sep; 34(9):811-826. PubMed ID: 35549368
[TBL] [Abstract][Full Text] [Related]
3. Sleep-Related Cannabis Expectancy Questionnaire (SR-CEQ): Initial Development among College Students.
Goodhines PA; LaRowe LR; Gellis LA; Ditre JW; Park A
J Psychoactive Drugs; 2020; 52(5):401-411. PubMed ID: 32772641
[TBL] [Abstract][Full Text] [Related]
4. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
Connor JP; Gullo MJ; Feeney GF; Young RM
Drug Alcohol Depend; 2011 Jun; 115(3):167-74. PubMed ID: 21163593
[TBL] [Abstract][Full Text] [Related]
6. Development and initial psychometric validation of the Brief-Caffeine Expectancy Questionnaire (B-CaffEQ).
Kearns NT; Blumenthal H; Natesan P; Zamboanga BL; Ham LS; Cloutier RM
Psychol Assess; 2018 Dec; 30(12):1597-1611. PubMed ID: 29927303
[TBL] [Abstract][Full Text] [Related]
7. The Cannabis Effects Expectancy Questionnaire-Medical (CEEQ-M): Preliminary psychometric properties and longitudinal validation within a clinical trial.
Weiss JH; Tervo-Clemmens B; Potter KW; Evins AE; Gilman JM
Psychol Assess; 2023 Aug; 35(8):659-673. PubMed ID: 37289502
[TBL] [Abstract][Full Text] [Related]
8. The Anticipated Effects of Alcohol Scale: development and psychometric evaluation of a novel assessment tool for measuring alcohol expectancies.
Morean ME; Corbin WR; Treat TA
Psychol Assess; 2012 Dec; 24(4):1008-1023. PubMed ID: 22708572
[TBL] [Abstract][Full Text] [Related]
9. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation.
Richards DK; Schwebel FJ; Sotelo M; Pearson MR;
Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399
[TBL] [Abstract][Full Text] [Related]
10. Psychometric validation of the Anticipated Effects of Alcohol Mixed with Energy Drinks Scale.
Norberg MM; Newins AR; Mills L; Ham LS
Psychol Assess; 2017 Dec; 29(12):1505-1516. PubMed ID: 28252975
[TBL] [Abstract][Full Text] [Related]
11. Cannabis expectancies in substance misusers: French validation of the Marijuana Effect Expectancy Questionnaire.
Guillem E; Notides C; Vorspan F; Debray M; Nieto I; Leroux M; Lépine JP
Am J Addict; 2011; 20(6):543-54. PubMed ID: 21999501
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous alcohol and cannabis expectancies predict simultaneous use.
Barnwell SS; Earleywine M
Subst Abuse Treat Prev Policy; 2006 Oct; 1():29. PubMed ID: 17034634
[TBL] [Abstract][Full Text] [Related]
13. Development and initial validation of a marijuana cessation expectancies questionnaire.
Metrik J; Farris SG; Aston ER; Kahler CW
Drug Alcohol Depend; 2017 Aug; 177():163-170. PubMed ID: 28600928
[TBL] [Abstract][Full Text] [Related]
14. A view through the gateway: expectancies as a possible pathway from alcohol to cannabis.
Willner P
Addiction; 2001 May; 96(5):691-703. PubMed ID: 11331028
[TBL] [Abstract][Full Text] [Related]
15. The prospective interactive effects of alcohol expectancies and subjective response on future drinking behavior.
Waddell JT; Corbin WR; Chassin L; Anderson SF
Exp Clin Psychopharmacol; 2022 Jun; 30(3):300-312. PubMed ID: 33180542
[TBL] [Abstract][Full Text] [Related]
16. The effects of cannabis use expectancies on self-initiated cannabis cessation.
Boden MT; McKay JR; Long WR; Bonn-Miller MO
Addiction; 2013 Sep; 108(9):1649-57. PubMed ID: 23627879
[TBL] [Abstract][Full Text] [Related]
17. Differential Role of Cannabis Use Motives in Predicting Impairment Across Three Measures.
Schultz NR; Bassett DT; Messina BG; Correia CJ
J Stud Alcohol Drugs; 2019 Jan; 80(1):26-31. PubMed ID: 30807271
[TBL] [Abstract][Full Text] [Related]
18. Psychometric assessment of the marijuana adolescent problem inventory.
Knapp AA; Babbin SF; Budney AJ; Walker DD; Stephens RS; Scherer EA; Stanger C
Addict Behav; 2018 Apr; 79():113-119. PubMed ID: 29288984
[TBL] [Abstract][Full Text] [Related]
19. Development and preliminary validation of the Anticipated Effects of Food Scale.
Cummings JR; Joyner MA; Gearhardt AN
Psychol Addict Behav; 2020 Mar; 34(2):403-413. PubMed ID: 31829666
[TBL] [Abstract][Full Text] [Related]
20. Social cognitive predictors of treatment outcome in cannabis dependence.
Gullo MJ; Matveeva M; Feeney GF; Young RM; Connor JP
Drug Alcohol Depend; 2017 Jan; 170():74-81. PubMed ID: 27883947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]